Standout Papers
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte (2010)
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments] (1990)
- Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials (2014)
Immediate Impact
11 by Nobel laureates 11 from Science/Nature 104 standout
Citing Papers
Acute myeloid leukaemia
2023 Standout
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
2022 Standout
Works of Sylvie Castaigné being referenced
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
2018
Outcome of older patients with acute myeloid leukemia in first relapse
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sylvie Castaigné | 5857 | 4981 | 1492 | 2029 | 165 | 9.0k | |
| Stanley R. Frankel | 2929 | 5085 | 1049 | 1740 | 72 | 7.9k | |
| Hitoshi Kiyoi | 5264 | 4333 | 1336 | 2019 | 275 | 8.8k | |
| David Grimwade | 12222 | 8014 | 4332 | 1696 | 145 | 14.9k | |
| Elisabeth Paietta | 7612 | 4629 | 4246 | 2902 | 272 | 12.6k | |
| Felicetto Ferrara | 3863 | 2564 | 1535 | 1120 | 193 | 5.6k | |
| Nigel H. Russell | 8701 | 4317 | 2438 | 3225 | 349 | 12.1k | |
| P. Maslak | 1660 | 2725 | 643 | 2985 | 96 | 6.1k | |
| Suresh C. Jhanwar | 1364 | 4015 | 376 | 2713 | 138 | 9.1k | |
| Gunnar Juliusson | 3229 | 2808 | 1457 | 2310 | 188 | 8.8k | |
| Steven Coutré | 4056 | 3391 | 1055 | 1766 | 235 | 10.3k |
All Works
Loading papers...